Complications and risk factors of infection in pediatric hemato-oncology patients with Totally Implantable Access Ports (TIAPs)

Pediatric Blood and Cancer

Volumn 54, Issue 4, 2010, Pages 546-551

  Nam, So Hyun ^a   Kim, Dae Yeon ^a   Kim, Seong Chul ^a   Kim, In Koo ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Catheter infection; Hematology; Oncology; Pediatrics; Totally implantable access port

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER PATIENT; CANCER SURGERY; CANDIDIASIS; CARCINOMA IN SITU; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILD DEATH; CHILDHOOD CANCER; CHILDHOOD LEUKEMIA; DEVICE INFECTION; DEVICE REMOVAL; EXTERNAL JUGULAR VEIN; FEMALE; FOLLOW UP; GERM CELL TUMOR; GRAM NEGATIVE INFECTION; HEPATOBLASTOMA; HISTIOCYTOSIS; HUMAN; IMPLANT; INFANT; INFECTION COMPLICATION; INFECTION RISK; INTERNAL JUGULAR VEIN; KLEBSIELLA PNEUMONIAE INFECTION; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NEPHROBLASTOMA; NEUROBLASTOMA; OPERATION DURATION; PRESCHOOL CHILD; PRIORITY JOURNAL; REIMPLANTATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SARCOMA; SCHOOL CHILD; SOLID TUMOR; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; SURGICAL TECHNIQUE; THROMBOCYTE COUNT; TOTALLY IMPLANTABLE ACCESS PORT; VASCULAR ACCESS; VASCULAR ACCESS DEVICE;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CATHETERIZATION, CENTRAL VENOUS; CHILD; CHILD, PRESCHOOL; DEVICE REMOVAL; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; NEOPLASMS; PROSTHESIS FAILURE; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 77649129099     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22286     Document Type: Article

References (18)

1. Broviac JW, Cole JJ, Scribner BH. A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet 1973;136:602-606.
2. Hickman RO, Buckner CD, Clift RA, et al. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet 1979;148:871-875.
3. Niederhuber JE, Ensminger W, Gyves JW, et al. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 1982;92:706-712.
4. Wiener ES, McGuire P, Stolar CJ, et al. The CCSG prospective study of venous access devices: An analysis of insertions and causes for removal. J Pediatr Surg 1992;27:155-164.
5. Munro FD, Gillett PM, Wratten JC, et al. Totally implantable central venous access devices for paediatric hematology-oncology patients. Med Pediatr Oncol 1999;33:377-381.
6. Babu R, Spicer RD. Implanted vascular access devices (ports) in children: Complications and their prevention. Pediatr Surg Int 2002;18:50-53.
7. Adler A, Yaniv I, Solter E, et al. Catheter-associated bloodstream infections in pediatric hematology-oncology patients: Factors associated with catheter removal and recurrence. J Pediatr Hematol Oncol 2006;28:23-28.
8. Adler A, Yaniv I, Steinberg R, et al. Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients. J Hosp Infect 2006;62:358-365.
9. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol 2002;23:759-769.
10. Dillon PA, Foglia RP. Complications associated with an implantable vascular access device. J Pediatr Surg 2006;41:1582-1587.
11. Rauthe G, Altmann C. Complications in connection with venous port systems: Prevention and therapy. Eur J Surg Oncol 1998;24:192-199.
12. Choi JY, Kim HY, Jung SE, et al. Inversion of implantable central venous port in children: 2 cases report. JKorean Assoc Pediatr Surg 2006;12:17-23.
13. Samaras P, Dold S, Braun J, et al. Infectious port complications are more frequent in younger patients with hematologic malignancies than in solid tumor patients. Oncology 2008;74:237-244.
14. Fischer L, Knebel P, Schröder S, et al. Reasons for removal of totally implantable access ports: A multivariate analysis of 385 consecutive patients. Ann Surg Oncol 2008;15:1124-1129.
15. Pagani O, Gelber S, Price K, et al. Toremifene and tamoxifen are equally effective for early-stage breast cancer: First results of International Breast Cancer Study Group Trials 12-93 and 14-93. Ann Oncol 2004;15:1749-1759.
16. Hotta T, Takifuji K, Arii K, et al. Toxicity during L-LV/5FU adjuvant chemotherapy as a modified RPMI regimen for patients with colorectal cancer. Oncol Rep 2005;14:433-439.
17. Sotir MJ, Lewis C, Bisher EW, et al. Epidemiology of device-associated infections related to a long-term implantable vascular access device. Infect Control Hosp Epidemiol 1999;20:187-191.
18. Sola JE, Stone MM, Colombani PM. Totally implantable vascular access devices in 131 pediatric hemato-oncology patients. Pediatr Surg Int 1996;11:156-158.